Reciprocal interaction and cross stimulation between MCPs producing vascular-endothelial growth factor (VEGF) and stromal cells producing IL-6 represent a potent regulatory mechanism contributing to increased vascularization in MM (74). The gene discussed is VEGFA; the disease is Miyoshi myopathy.